Columbus Venture Partners

Vivet Therapeutics is a clinical-stage biotechnology company developing recombinant adeno-associated virus (rAAV) gene therapies for rare, inherited metabolic diseases, including Wilson's Disease and cerebrotendinous xanthomatosis.

BiotechHealthtechParis, FR

PartnerJose Mesa· solo GP

Co-investorsHealthCapKurma PartnersNovartis Venture FundRoche Venture FundYsios CapitalEurazeo+1 more

Accipiter Biosciences uses computational protein design to develop de novo, single-agent protein therapies that engage multiple cell-surface receptors at once, functioning as agonists.

AI & Machine LearningBiotechDeep TechSeattle, US

Matthew Bick(Executive Officer, Director, Promoter)inJavier Castellanos(Executive Officer, Director, Promoter)Hector De Jesus Rincon Arano(Executive Officer, Promoter)Heather Redman(Director)Randall Schatzman(Director)William Canestaro(Executive Officer)

PartnerJose Mesa· solo GP

Co-investorsArgonautic VenturesPack VenturesWRF Capital

PartnerJose Mesa· solo GP

Aleta Biotherapeutics develops multi-antigen CAR T Engager (CTE) biologics designed to improve the effectiveness of CAR T cell cancer therapies by increasing target antigen density and preventing cancer escape.

BiotechDeep TechHealthtech

PartnerJose Mesa· solo GP

Algenex develops and produces recombinant proteins and biologics using its CrisBio technology platform, serving animal health, human health, and diagnostics markets.

BiotechDeep TechMedical Devices

PartnerJose Mesa· solo GP

Alto Pharmacy is a full-service pharmacy that offers patients medication delivery, cost transparency, and pharmacist access.

ConsumerDigital HealthHealthtechSan Francisco, US

PartnerJose Mesa· solo GP

Co-investorsAvego BioScience CapitalBantam GroupCalm VenturesCSC UpshotEvolution VC PartnersFlucas Ventures+7 more

Artax Biopharma is a Phase 2 clinical-stage biotechnology company developing first-in-class oral small-molecule Nck modulators that target T cell receptor Signal 1 activation to treat autoimmune diseases without causing immunosuppression.

BiotechHealthtechCambridge, US

Damia Tormo(President, CEO, Treasurer and Founder)Joe Suarez(Executive Officer)Maria Nichol(Executive Officer)Robert W. Armstrong, Ph.D.(Executive Officer, Director)Rob Armstrong(CEO)Jan de Vries, Ph.D.(Director)

PartnerJose Mesa· solo GP

Co-investorsSound BioventuresAdvent Life Sciences

Arthex Biotech develops an investigational anti-miR therapeutic targeting an upregulated miRNA for the treatment of myotonic dystrophy, aiming to address the root cause of the disease.

BiotechMedical Devices

PartnerJose Mesa· solo GP

Co-investorsAdBio partnersInvivo Capital PartnersSound Bioventures

AskBio develops gene therapies based on adeno-associated virus (AAV) technology, with a clinical pipeline targeting central nervous system, neuromuscular, metabolic, and cardiovascular disorders.

BiotechDigital HealthHealthtechMedical DevicesDurham, US

PartnerJose Mesa· solo GP

Co-investorsTPGVida Ventures

Cocoon Bioscience operates CrisBio, a recombinant protein expression platform that uses insects in a chrysalis (cocoon) state instead of traditional bioreactors to produce enzymes and complex proteins.

BiotechDeep TechNew Materials

PartnerJose Mesa· solo GP

Curapath (formerly PTS) is a contract development and manufacturing organization (CDMO) specializing in non-viral drug delivery systems, including polymer and lipid nanoparticle formulations and functional excipients.

Advanced ManufacturingBiotechMedical Devices

PartnerJose Mesa· solo GP

Curve Therapeutics is a drug discovery company that uses a proprietary gene-encoded, high-throughput intracellular platform to screen libraries of cyclic peptides inside live mammalian cells.

AI & Machine LearningBiotechDeep Tech

PartnerJose Mesa· solo GP

Co-investorsEpidarex CapitalPfizer Venture Investments

Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.

Medical Devices

Co-investorsAsabys Partners

A digital agency offering design and development services—including 3D space configuration, digitizing physical samples into online catalogs, and ticket-sales platforms—for brands across multiple sectors.

Marketing TechSaaS

Highlight Therapeutics develops RNA-based immunotherapies for dermato-oncology, with a lead intra-lesional drug candidate, BO-112, aimed at triggering an immune response against skin cancers.

BiotechHealthtech

PartnerJose Mesa· solo GP

Co-investorsDroia Ventures

PartnerJose Mesa· solo GP

Co-investorsAdBio partnersInvivo Capital Partners

Jurata develops thermostable formulations for biologics, vaccines, and advanced therapeutics that reduce or eliminate cold chain and special handling needs.

BiotechDeep TechHealthtech

PartnerJose Mesa· solo GP

Lark develops an AI-powered health coaching platform that delivers personalized support for chronic disease prevention and management through 24/7 text-based conversations and integration with smart health devices.

AI & Machine LearningDigital HealthHealthtech

Julia Hu(Founder)

PartnerJose Mesa· solo GP

Co-investorsAlpha Intelligence CapitalAsset Management CompanyCrunchFundIPD CapitalJoyance PartnersKing River Capital+5 more

Minoryx is a biopharmaceutical company that discovers and develops drug treatments for severe orphan diseases of the central nervous system, such as cerebral adrenoleukodystrophy and Rett syndrome.

BiotechHealthtech

PartnerJose Mesa· solo GP

Co-investorsChiesi VenturesCriteria Bio VenturesFund+Invivo Capital PartnersKurma PartnersRoche Venture Fund+1 more

PartnerJose Mesa· solo GP

Co-investorsAdvent Life SciencesFountain Healthcare PartnersOrbiMed

Ona provides secure cloud workspaces for running AI coding agents, giving each agent a full cloud development environment with network access, permissions, and runtime controls.

AI & Machine LearningCloud ComputingDeveloper Tools

Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesAlta Life SciencesKorys+1 more

Ona Therapeutics is a biotechnology company developing first-in-class antibody drug conjugates (ADCs) and antibody therapies targeting the molecular biology of treatment-refractory advanced cancers.

BiotechHealthtech

Co-investorsFund+KorysMérieux Equity PartnersYsios CapitalAlta Life SciencesAsabys Partners+2 more

Quatre Lab (Quality Advanced Therapies Research, S.L.) provides outsourced quality control testing and certification services for advanced therapy medicinal products (ATMPs), helping developers meet regulatory agency requirements for clinical use and market launch.

BiotechDeep TechHealthtech

PartnerJose Mesa· solo GP

Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies.

AI & Machine LearningHealthtechMedical Devices

PartnerJose Mesa· solo GP

Co-investorsAdara VenturesAmadeus Capital PartnersLifeX VenturesAsabys PartnersGoHub Ventures

PartnerJose Mesa· solo GP

PartnerJose Mesa· solo GP

Advanced ManufacturingBiotechDeep TechWatertown, US

PartnerJose Mesa· solo GP

Co-investorsBuenavista Equity Partners

TAAV Biomanufacturing Solutions is a CDMO producing enzymatic DNA (neDNA), an alternative to plasmids used as starting material for recombinant AAV (rAAV) production in gene therapy.

BiotechDeep TechHealthtechSan Sebastian, ES

PartnerJose Mesa· solo GP

Tyris develops a platform for DNA-based therapies, combining DNA optimisation with non-viral delivery to extend the reach of genetic treatments.

BiotechDeep TechHealthtechValencia, ES

PartnerJose Mesa· solo GP

Viralgen is a contract development and manufacturing organization (CDMO) focused exclusively on cGMP AAV-based gene therapy vector manufacturing, using a proprietary suspension triple-transfection platform with the AskBio Pro10 HEK293 cell line.

Advanced ManufacturingBiotechHealthtechSan Sebastián, ES

Jimmy Vanhove(CEO)

PartnerJose Mesa· solo GP